# Quicktome Software Suite

> Active: European Union and United States. Medical device record on deviCERTS, compiled from public registries.

- Canonical page: <https://devicerts.com/devices/quicktome-software-suite-llz>
- Manufacturer: [Omniscient Neurotechnology Pty Ltd (O8t)](https://devicerts.com/manufacturers/omniscient-neurotechnology-pty-ltd-o8t) (Australia, FDA 510(k) applicant)
- Device class: Class II (US FDA)
- FDA product code: LLZ

## Overview

*AI-generated summary, 2026-09-18. Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data is the record.*

The Quicktome Software Suite is a connectomic analysis platform designed for advanced brain mapping and functional imaging analysis. It leverages AI-enabled post-processing to analyze MRI and resting-state functional MRI (rs-fMRI) data, generating detailed insights into patient-specific brain networks and connectivity patterns. This software supports neurosurgical planning by providing precise, actionable visualizations of brain structures and pathways.

The Quicktome Software Suite is supplied as a digital platform for use in clinical settings, including neurosurgical planning environments. It is intended for single-use per patient analysis, with no specified sterility requirements as it is non-invasive software. The system operates under FDA 510(k) clearance (K222359) and EU MDR compliance, with no restrictions on MRI safety as it is not a physical device. No physical storage or disposal requirements apply beyond standard IT infrastructure protocols.

## Registrations and authorizations

- **510(k)** · FDA 510(k) · United States · K222359 · decision 2023-05-30 · decision SESE · status: Active
- **EUDAMED** · CE/MDR · European Union · status: Active

## Recalls

No recall on record.

## Identifiers

- 510(k) Number: K222359 [FDA 510(k)]
- FDA product code: LLZ [FDA 510(k)]

## Classification

- Device class: Class II [FDA 510(k)]
- Regulation: 21 CFR Part 892.2050 [FDA 510(k)]
- Advisory committee: Radiology [FDA 510(k)]
- FDA decision: SESE [FDA 510(k)]

## Source and citation

- Cite as: Quicktome Software Suite, Omniscient Neurotechnology Pty Ltd (O8t). deviCERTS medical device catalogue. https://devicerts.com/devices/quicktome-software-suite-llz (data as of 2026-11-20).
- Data sources: [FDA 510(k)](https://open.fda.gov/apis/device/510k/), [EUDAMED](https://ec.europa.eu/tools/eudamed)
- Registry records last synced: 2026-10-22
- Statuses computed as of: 2026-11-20
- JSON: <https://devicerts.com/devices/quicktome-software-suite-llz.json>
- Licence: [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/). The deviCERTS layout and text are licensed under CC BY 4.0. Registry data remain under their source terms: U.S. FDA data (openFDA, AccessGUDID) are U.S. public domain; EUDAMED data are subject to the European Commission reuse terms.
- Attribution: DevicErts, https://devicerts.com/devices/quicktome-software-suite-llz
- Compiled by deviCERTS (devicerts.com) from public medical device registries (EUDAMED, European Commission; U.S. FDA via openFDA; AccessGUDID, U.S. National Library of Medicine). deviCERTS is not an official register and gives no regulatory advice: the record in the registry itself prevails.
